These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


457 related items for PubMed ID: 23562616

  • 21. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.
    Invernizzi R, Velasco C, Bramante M, Longo A, Samanin R.
    Neuropharmacology; 1997; 36(4-5):467-73. PubMed ID: 9225271
    [Abstract] [Full Text] [Related]

  • 22. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I, Bel N, Fernández AG, Palacios JM, Artigas F.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [Abstract] [Full Text] [Related]

  • 23. Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters--a rat microdialysis and electrophysiology study.
    Pehrson AL, Cremers T, Bétry C, van der Hart MG, Jørgensen L, Madsen M, Haddjeri N, Ebert B, Sanchez C.
    Eur Neuropsychopharmacol; 2013 Feb; 23(2):133-45. PubMed ID: 22612991
    [Abstract] [Full Text] [Related]

  • 24. Effect of subchronic lithium treatment on citalopram-induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex.
    Muraki I, Inoue T, Hashimoto S, Izumi T, Ito K, Koyama T.
    J Neurochem; 2001 Jan; 76(2):490-7. PubMed ID: 11208912
    [Abstract] [Full Text] [Related]

  • 25. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P, Kehr J, Scheel-Krüger J.
    J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
    [Abstract] [Full Text] [Related]

  • 26. Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: a review.
    Guiard BP, Lanfumey L, Gardier AM.
    Curr Drug Targets; 2006 Feb; 7(2):187-201. PubMed ID: 16475960
    [Abstract] [Full Text] [Related]

  • 27. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo.
    Auerbach SB, Hjorth S.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):597-606. PubMed ID: 9053730
    [Abstract] [Full Text] [Related]

  • 28. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
    Lucas G, Du J, Romeas T, Mnie-Filali O, Haddjeri N, Piñeyro G, Debonnel G.
    PLoS One; 2010 Feb 16; 5(2):e9253. PubMed ID: 20169084
    [Abstract] [Full Text] [Related]

  • 29. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.
    Asaoka N, Nagayasu K, Nishitani N, Yamashiro M, Shirakawa H, Nakagawa T, Kaneko S.
    Neuropharmacology; 2015 Aug 16; 95():261-8. PubMed ID: 25863120
    [Abstract] [Full Text] [Related]

  • 30. Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis.
    Boothman LJ, Mitchell SN, Sharp T.
    Neuropharmacology; 2006 May 16; 50(6):726-32. PubMed ID: 16434063
    [Abstract] [Full Text] [Related]

  • 31. Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.
    Chenu F, Guiard BP, Bourin M, Gardier AM.
    Behav Brain Res; 2006 Sep 25; 172(2):256-63. PubMed ID: 16806519
    [Abstract] [Full Text] [Related]

  • 32. Alpha1-adrenoceptors modulate citalopram-induced serotonin release.
    Rea K, Folgering J, Westerink BH, Cremers TI.
    Neuropharmacology; 2010 Jun 25; 58(7):962-71. PubMed ID: 20043931
    [Abstract] [Full Text] [Related]

  • 33. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T, Umbers V, Gartside SE.
    Br J Pharmacol; 1997 Jul 25; 121(5):941-6. PubMed ID: 9222551
    [Abstract] [Full Text] [Related]

  • 34. L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo.
    Miguelez C, Navailles S, Delaville C, Marquis L, Lagière M, Benazzouz A, Ugedo L, De Deurwaerdère P.
    Eur Neuropsychopharmacol; 2016 Aug 25; 26(8):1297-309. PubMed ID: 27234917
    [Abstract] [Full Text] [Related]

  • 35. [Anxiolytic effects of serotonin reuptake inhibitors and their mechanism of action].
    Hashimoto S.
    Hokkaido Igaku Zasshi; 2000 Nov 25; 75(6):421-36. PubMed ID: 11193934
    [Abstract] [Full Text] [Related]

  • 36. Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels.
    Bundgaard C, Larsen F, Jørgensen M, Gabrielsson J.
    Eur J Pharm Sci; 2006 Dec 25; 29(5):394-404. PubMed ID: 17014998
    [Abstract] [Full Text] [Related]

  • 37. Effects of sustained administration of quetiapine alone and in combination with a serotonin reuptake inhibitor on norepinephrine and serotonin transmission.
    Chernoloz O, El Mansari M, Blier P.
    Neuropsychopharmacology; 2012 Jun 25; 37(7):1717-28. PubMed ID: 22373941
    [Abstract] [Full Text] [Related]

  • 38. Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats.
    Hashimoto S, Inoue T, Koyama T.
    Eur J Pharmacol; 1999 Jul 28; 378(1):23-30. PubMed ID: 10478561
    [Abstract] [Full Text] [Related]

  • 39. [Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate].
    Muraki I.
    Hokkaido Igaku Zasshi; 2001 Mar 28; 76(2):57-70. PubMed ID: 11344903
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.